Peili Cen

Peili Cen

Auto-generated profile, based on publicly available information

Peili Cen

Department of Nuclear Medicine Zhejiang Cancer Hospital Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences Hangzhou China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2023 in Aggregate
Verified
Journal Article
Open access
PCPeili Cen
Peili Cen
JHJiani Huang
Jiani Huang
CJChentao Jin
Chentao Jin
JWJing Wang
Jing Wang
YWYen Wei
Yen Wei
MTMei Tian
Mei Tian
Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photostability. AIEgens can specifically target different types of cancer via diverse targeting strategies. AIEgen‐based fluorescence imaging, especially near‐infrared imaging, demonstrated deep penetration and suitable signal‐to‐noise ratio, which allows reliable in vivo cancer imaging. Combined with other imaging modalities, AIEgen‐based multimodal imaging could provide multidimensional cancer hallmarks from different perspectives. In addition, AIEgen‐based phototherapy can be used for photodynamic therapy and photothermal therapy, which facilitate ablation of cancer cells with good biosafety and high therapeutic effects in vivo. AIEgens nanoparticles fabricated with some specific chemicals, drugs, or siRNA, could display synergistic therapeutic effects for cancers. This paper comprehensively describes the current status and future perspectives of AIEgens, which have showed a great potential for the future preclinical and clinical translation on in vivo molecular imaging and theranostics in cancer.

13 August 2024 in Journal of Advanced Research
Verified
Journal Article
Open access
YLYin Li
Yin Li
HZHang Zhou
Hang Zhou
XHXuchao He
Xuchao He
LJLingji Jin
Lingji Jin
YZYuhan Zhu
Yuhan Zhu
LWLin Wang
Lin Wang
Intracerebral haemorrhage (ICH) is a devastating disease that leads to severe neurological deficits. Microglia are the first line of defence in the brain and play a crucial role in neurological recovery after ICH, whose activities are primarily driven by glucose metabolism. However, little is known regarding the status of glucose metabolism in microglia and its interactions with inflammatory responses after ICH. This study investigated microglial glycolysis and its mechanistic effects on microglial inflammation after ICH. We explored the status of glucose metabolism in the ipsilateral region and in fluorescence-activated-cell-sorting-isolated (FACS-isolated) microglia via 2-deoxy-[18F]fluoro-D-glucose positron emission tomography (FDG-PET) analyses and gamma emission, respectively. Energy-related targeted metabolomics, along with 13C-glucose isotope tracing, was utilised to analyse glycolytic products in microglia. Mitochondrial membrane potential and mitochondrial reactive oxygen species (MitoROS) accumulation was assessed by flow cytometry. Behavioural, western blotting, gene regulation, and enzymatic activity analyses were conducted with a focus on microglia. Neurological dysfunction was strongly correlated with decreased FDG-PET signals in the perihaematomal region, where microglial uptake of FDG was reduced. The decreased quantity of glucose-6-phosphate (G-6-P) in microglia was attributed to the downregulation of glucose transporter 1 (GLUT1) and hexokinase 2 (HK2). Enhanced inflammatory responses were driven by HK2 suppression via decreased mitochondrial membrane potential, which could be rescued by MitoROS scavengers. HK inhibitors aggravated neurological injury by suppressing FDG uptake and enhancing microglial inflammation in ICH mice. These findings indicate an unexpected metabolic status in pro-inflammatory microglia after ICH, consisting of glycolysis impairment caused by the downregulation of GLUT1 and HK2. Additionally, HK2 suppression promotes inflammatory responses by disrupting mitochondrial function, providing insight into the mechanisms by which inflammation may be facilitated after ICH and indicating that metabolic enzymes as potential targets for ICH treatment.

30 March 2024 in Acta Biomaterialia
Verified
Journal Article
Closed access
PCPeili Cen
Peili Cen
CCChunyi Cui
Chunyi Cui
JHJiani Huang
Jiani Huang
HCHetian Chen
Hetian Chen
FWFei Wu
Fei Wu
MTMei Tian
Mei Tian

3 June 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
XHXiao He
Xiao He
JCJiadong Chen
Jiadong Chen
YZYan Zhong
Yan Zhong
PCPeili Cen
Peili Cen
LSLi Shen
Li Shen
HZHong Zhang
Hong Zhang
Human cortical neural progenitor cell transplantation holds significant potential in cortical stroke treatment by replacing lost cortical neurons and repairing damaged brain circuits. However, commonly utilized human cortical neural progenitors are limited in yield a substantial proportion of diverse cortical neurons and require an extended period to achieve functional maturation and synaptic integration, thereby potentially diminishing the optimal therapeutic benefits of cell transplantation for cortical stroke. Here, we generated forkhead box G1 (FOXG1)-positive forebrain progenitors from human inducible pluripotent stem cells, which can differentiate into diverse and balanced cortical neurons including upper- and deep-layer excitatory and inhibitory neurons, achieving early functional maturation simultaneously in vitro. Furthermore, these FOXG1 forebrain progenitor cells demonstrate robust cortical neuronal differentiation, rapid functional maturation and efficient synaptic integration after transplantation into the sensory cortex of stroke-injured adult rats. Notably, we have successfully utilized the non-invasive 18F-SynVesT-1 PET imaging technique to assess alterations in synapse count before and after transplantation therapy of FOXG1 progenitors in vivo. Moreover, the transplanted FOXG1 progenitors improve sensory and motor function recovery following stroke. These findings provide systematic and compelling evidence for the suitability of these FOXG1 progenitors for neuronal replacement in ischemic cortical stroke.

1 September 2025 in Radiology
Verified
Journal Article
Closed access
XLXiaoyi Li
Xiaoyi Li
YZYan Zhong
Yan Zhong
CJChentao Jin
Chentao Jin
XCXiang Chen
Xiang Chen
XCXingyue Cui
Xingyue Cui
HZHong Zhang
Hong Zhang
A clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (known as CRISPR/Cas9)–engineered triple-fusion reporter gene imaging system combined with a noninvasive agonistic micelle-based approach enabled in vivo monitoring of transplanted human neural progenitor cells in a rat model of ischemic stroke.

8 November 2025 in The Innovation
Verified
Journal Article
Open access
PCPeili Cen
Peili Cen
CJChentao Jin
Chentao Jin
JWJing Wang
Jing Wang
YZYan Zhong
Yan Zhong
MTMei Tian
Mei Tian
HZHong Zhang
Hong Zhang